Valuation Stryker Corporation Borsa Italiana
Stocks
1SYK
US8636671013
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
09:04:35 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 289.85 EUR | -1.08% |
|
-0.68% | -2.37% |
| 06:25am | Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating | MT |
| 08-13 | Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating | MT |
Company Valuation: Stryker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 100,882 | 92,522 | 113,776 | 137,257 | 134,410 | 127,224 | - | - |
| Change | - | -8.29% | 22.97% | 20.64% | -2.07% | -5.35% | - | - |
| Enterprise Value (EV) 1 | 110,335 | 102,451 | 121,655 | 144,952 | 146,258 | 136,349 | 133,112 | 129,734 |
| Change | - | -7.14% | 18.74% | 19.15% | 0.9% | -6.78% | -2.37% | -2.54% |
| P/E | 51.3x | 39.6x | 36.3x | 46.4x | 41.8x | 25.8x | 22.4x | 19.9x |
| PBR | 6.79x | 5.56x | 6.11x | 6.65x | 5.99x | 4.83x | 4.17x | 3.59x |
| PEG | - | 2.1x | 1.1x | -7.81x | 5.07x | 0.5x | 1.5x | 1.6x |
| Capitalization / Revenue | 5.9x | 5.02x | 5.55x | 6.07x | 5.35x | 4.66x | 4.29x | 3.98x |
| EV / Revenue | 6.45x | 5.55x | 5.93x | 6.42x | 5.82x | 5x | 4.48x | 4.05x |
| EV / EBITDA | 23.2x | 21.5x | 22.7x | 23.6x | 20.7x | 17.2x | 15.5x | 13.7x |
| EV / EBIT | 25.2x | 23.4x | 24.6x | 25.4x | 22.2x | 18.7x | 16.5x | 14.6x |
| EV / FCF | 40.3x | 50.3x | 39.2x | 41.6x | 34.1x | 35.3x | 26.5x | 22.3x |
| FCF Yield | 2.48% | 1.99% | 2.55% | 2.41% | 2.93% | 2.83% | 3.78% | 4.49% |
| Dividend per Share 2 | 2.585 | 2.835 | 3.05 | 3.24 | 3.4 | 3.6 | 3.832 | 4.118 |
| Rate of return | 0.97% | 1.16% | 1.02% | 0.9% | 0.97% | 1.09% | 1.16% | 1.24% |
| EPS 2 | 5.21 | 6.17 | 8.25 | 7.76 | 8.4 | 12.88 | 14.78 | 16.66 |
| Distribution rate | 49.6% | 45.9% | 37% | 41.8% | 40.5% | 28% | 25.9% | 24.7% |
| Net sales 1 | 17,108 | 18,449 | 20,498 | 22,595 | 25,116 | 27,292 | 29,681 | 31,999 |
| EBITDA 1 | 4,753 | 4,755 | 5,348 | 6,142 | 7,064 | 7,944 | 8,592 | 9,464 |
| EBIT 1 | 4,382 | 4,384 | 4,955 | 5,715 | 6,603 | 7,296 | 8,065 | 8,907 |
| Net income 1 | 1,994 | 2,358 | 3,165 | 2,993 | 3,246 | 4,942 | 5,746 | 6,398 |
| Net Debt 1 | 9,453 | 9,929 | 7,879 | 7,695 | 11,848 | 9,125 | 5,888 | 2,511 |
| Reference price 2 | 267.42 | 244.49 | 299.46 | 360.05 | 351.47 | 331.68 | 331.68 | 331.68 |
| Nbr of stocks (in thousands) | 377,240 | 378,430 | 379,938 | 381,216 | 382,424 | 383,573 | - | - |
| Announcement Date | 1/27/22 | 1/31/23 | 1/30/24 | 1/28/25 | 1/29/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 25.76x | 5x | 17.16x | 1.09% | 127B | |
| 18.49x | 2.35x | 9.17x | 2.77% | 12.41B | |
| -229.48x | 15.59x | 1850.62x | -.--% | 10.94B | |
| 22.4x | 10.43x | 17.5x | 1.94% | 4.45B | |
| 26.32x | - | - | - | 2.67B | |
| 17.83x | 4.82x | 9.42x | 3.43% | 1.66B | |
| -1327.61x | 1.54x | 7.21x | -.--% | 1.65B | |
| Average | -206.61x | 6.62x | 318.51x | 1.54% | 23B | |
| Weighted average by Cap. | -6.22x | 5.64x | 143.08x | 1.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SYK Stock
- 1SYK Stock
- Valuation Stryker Corporation
Select your edition
All financial news and data tailored to specific country editions
